Predictive Significance of Mucinous Histology on Pathologic Complete Response Rate Following Capecitabine-Based Neoadjuvant Chemoradiation in Rectal Cancer: a Comparative Study-Reference-Cited by-同舟云学术

Predictive Significance of Mucinous Histology on Pathologic Complete Response Rate Following Capecitabine-Based Neoadjuvant Chemoradiation in Rectal Cancer: a Comparative Study

Published:2018-07-09 Issue:4 Volume:50 Page:716-722
ISSN:1941-6628
Container-title:Journal of Gastrointestinal Cancer
language:en
Short-container-title:J Gastrointest Canc

Author:

Hosseini Sare,Nguyen NamPhong,Mohammadianpanah Mohammad^ORCID,Mirzaei Sepideh,Bananzadeh Ali Mohammad

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s12029-018-0136-x.pdf

Reference45 articles.

1. Rule W, Meyer J. Current status of radiation therapy for the management of rectal cancer. Crit Rev Oncog. 2012;17(4):331–43.

2. Kaiser AM, Klaristenfeld D, Beart RW. Preoperative versus postoperative radiotherapy for rectal cancer in a decision analysis and outcome prediction model. Ann Surg Oncol. 2012;19(13):4150–60. https://doi.org/10.1245/s10434-012-2445-9.

3. Nelson VM, Benson AB 3rd. Pathological complete response after neoadjuvant therapy for rectal cancer and the role of adjuvant therapy. Curr Oncol Rep. 2013;15(2):152–61. https://doi.org/10.1007/s11912-013-0297-5.

4. Diaz-Gonzalez JA, Calvo FA, Cortes J, Garcia-Sabrido JL, Gomez-Espi M, Del Valle E, et al. Prognostic factors for disease-free survival in patients with T3-4 or N+ rectal cancer treated with preoperative chemoradiation therapy, surgery, and intraoperative irradiation. Int J Radiat Oncol Biol Phys. 2006;64(4):1122–8.

5. Martin ST, Heneghan HM, Winter DC. Systematic review of outcomes after intersphincteric resection for low rectal cancer. Br J Surg. 2012;99(5):603–12. https://doi.org/10.1002/bjs.8677.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Population-Based and Propensity Score-Matched Investigation of the Occurrence, Management, and Prognosis of Anal Mucinous Adenocarcinoma Patients;Oncology Research and Treatment;2024-06-27

2. Neoadjuvant chemotherapy improves survival in patients with oesophageal mucinous adenocarcinoma: Post-hoc analysis of the UK MRC OE02 and OE05 trials;European Journal of Cancer;2022-07

3. CT and 3 Tesla MRI in the TN Staging of Colon Cancer: A Prospective, Blind Study;Current Oncology;2022-02-13

4. Can histologic features predict neoadjuvant therapy response in rectal adenocarcinoma?;Pathology - Research and Practice;2021-10

5. Does the efficacy of regorafenib differ in chemotherapy refractory metastatic colorectal cancer patients who had mucinous pathology compared to those who had non-mucinous pathology?;Current Problems in Cancer;2021-06